Kroy DC - Search Results

1

c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.

Drescher HK, Schumacher F, Schenker T, Baues M, Lammers T, Hieronymus T, Trautwein C, Streetz KL, Kroy DC. Drescher HK, et al. Among authors: kroy dc. Oxid Med Cell Longev. 2018 Nov 12;2018:6957497. doi: 10.1155/2018/6957497. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30538805 Free PMC article.

2

Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.

Kroy DC, Schumacher F, Ramadori P, Hatting M, Bergheim I, Gassler N, Boekschoten MV, Müller M, Streetz KL, Trautwein C. Kroy DC, et al. J Hepatol. 2014 Oct;61(4):883-90. doi: 10.1016/j.jhep.2014.05.019. Epub 2014 May 15. J Hepatol. 2014. PMID: 24845607

3

Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.

Ramadori P, Drescher H, Erschfeld S, Schumacher F, Berger C, Fragoulis A, Schenkel J, Kensler TW, Wruck CJ, Trautwein C, Kroy DC, Streetz KL. Ramadori P, et al. Among authors: kroy dc. Free Radic Biol Med. 2016 Feb;91:114-26. doi: 10.1016/j.freeradbiomed.2015.12.014. Epub 2015 Dec 15. Free Radic Biol Med. 2016. PMID: 26698665

4

β₇-Integrin and MAdCAM-1 play opposing roles during the development of non-alcoholic steatohepatitis.

Drescher HK, Schippers A, Clahsen T, Sahin H, Noels H, Hornef M, Wagner N, Trautwein C, Streetz KL, Kroy DC. Drescher HK, et al. Among authors: kroy dc. J Hepatol. 2017 Jun;66(6):1251-1264. doi: 10.1016/j.jhep.2017.02.001. Epub 2017 Feb 10. J Hepatol. 2017. PMID: 28192190

5

Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.

Ramadori P, Drescher H, Erschfeld S, Fragoulis A, Kensler TW, Wruck CJ, Cubero FJ, Trautwein C, Streetz KL, Kroy DC. Ramadori P, et al. Among authors: kroy dc. Oxid Med Cell Longev. 2017;2017:3420286. doi: 10.1155/2017/3420286. Epub 2017 Jun 6. Oxid Med Cell Longev. 2017. PMID: 28676836 Free PMC article.

6

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, Kotsiliti E, Leone V, Peiseler M, Surewaard BGJ, Rath D, Ali A, Wolf MJ, Drescher H, Healy ME, Dauch D, Kroy D, Krenkel O, Kohlhepp M, Engleitner T, Olkus A, Sijmonsma T, Volz J, Deppermann C, Stegner D, Helbling P, Nombela-Arrieta C, Rafiei A, Hinterleitner M, Rall M, Baku F, Borst O, Wilson CL, Leslie J, O'Connor T, Weston CJ, Chauhan A, Adams DH, Sheriff L, Teijeiro A, Prinz M, Bogeska R, Anstee N, Bongers MN, Notohamiprodjo M, Geisler T, Withers DJ, Ware J, Mann DA, Augustin HG, Vegiopoulos A, Milsom MD, Rose AJ, Lalor PF, Llovet JM, Pinyol R, Tacke F, Rad R, Matter M, Djouder N, Kubes P, Knolle PA, Unger K, Zender L, Nieswandt B, Gawaz M, Weber A, Heikenwalder M. Malehmir M, et al. Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1. Nat Med. 2019. PMID: 30936549 Free article.

7

Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation.

Sander LE, Obermeier F, Dierssen U, Kroy DC, Singh AK, Seidler U, Streetz KL, Lutz HH, Müller W, Tacke F, Trautwein C. Sander LE, et al. Among authors: kroy dc. J Immunol. 2008 Sep 1;181(5):3586-94. doi: 10.4049/jimmunol.181.5.3586. J Immunol. 2008. PMID: 18714032

8

Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.

Kroy DC, Beraza N, Tschaharganeh DF, Sander LE, Erschfeld S, Giebeler A, Liedtke C, Wasmuth HE, Trautwein C, Streetz KL. Kroy DC, et al. Hepatology. 2010 Feb;51(2):463-73. doi: 10.1002/hep.23322. Hepatology. 2010. PMID: 19918973

9

Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

Plum W, Tschaharganeh DF, Kroy DC, Corsten E, Erschfeld S, Dierssen U, Wasmuth H, Trautwein C, Streetz KL. Plum W, et al. Among authors: kroy dc. Am J Pathol. 2010 May;176(5):2236-46. doi: 10.2353/ajpath.2010.090469. Epub 2010 Apr 9. Am J Pathol. 2010. PMID: 20382701 Free PMC article.

10

The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis.

Hansel C, Erschfeld S, Baues M, Lammers T, Weiskirchen R, Trautwein C, Kroy DC, Drescher HK. Hansel C, et al. Among authors: kroy dc. Front Pharmacol. 2019 Mar 13;10:244. doi: 10.3389/fphar.2019.00244. eCollection 2019. Front Pharmacol. 2019. PMID: 30949049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page